Introduction Today, GLP-1 drugs are most commonly used for diabetes and weight loss, but there is potential for GLP-1 therapies to transform healthcare by offering new solutions for managing chronic conditions
Deficiency leads to megaloblastic anaemia (pernicious anaemia), causing fatigue and weakness
From an experimental perspective, this means that BPC-157 can be used as a tool to study angiogenesis, endothelial signaling and the organization of the vascular response in in vitro and in vivo models
100% Authentic Numbuzin skincare
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF